Print Page | Contact Us | Sign In | Join FSN
Diabetic Nephropathy Clinical Trials
 Diabetic Nephropathy 

Name or Title of Research Study

Randomized, Double-Arm, Deferred Treatment, Open-Label, Repeat Dose, Of Autologous Neo-Kidney Augmentâ„¢ (NKA) In Subjects With Type 2 Diabetes And Chronic Kidney Disease

Enrollment Criteria
Male or female, 30 to 80 years of age and has type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) with an estimated glomerular filtration rate (eGFR) between 20 and 50 mL/min/1.73m2 inclusive .

Treatment: Autologous selected renal cells (SRC)

Institution: UF Nephrology

Contact for Enrollment
Sherry Brown, BSN, RN, Clinical Trials Manager | 352-273-5661

Diabetic Nephropathy 

Title of Research Study: TRIDENT: Transformative Research In DiabEtic NephropaThy 

PI: Dr. Lenz
Sponsor: Boehringer Ingelheim-Glaxo Smith Kline Regeneron-Gilead Science
 Active/Enrolled/InScreening: 5/14/2

Institution: UM Nephrology
Contact for Enrollment:
Jacqueline Vassallo, CCRP.
Tel: 305-243-4691 

1215 E. Robinson Street, Orlando, FL 32801
Phone: 813-909-0450  |  Fax: 813-949-8994